|
Salix Pharmaceuticals is a finishing school for tummy drugs. Focusing on drugs for gastrointestinal diseases, the company shops for drug candidates nearing commercial viability. It then takes them through the final development stages and brings them to market. The company's marketed products include Colazal (for ulcerative colitis), Azasan (immune system suppressant), Proctocort (hydrocortisone for hemorrhoids), and Xifaxan (an antibiotic for travelers' diarrhea). Other products include colonoscopy preparatory bowel purgatives OsmoPrep and Visicol. Its late-stage candidates include both new drugs and new uses for existing drugs. Salix's sales and marketing team primarily targets US gastroenterologists.
|
| | | Contact Information | |
Address: |
1700 Perimeter Park Dr.
Morrisville, NC 27560-8404
| | Phone: | 919-862-1000 | | Fax: | 919-862-1095 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 178.80 M | | Revenue Growth (1 yr): | (-24.20%) | | Employees (2008): | 280 | | Employee Growth (1 yr): | 3.70% |
|
|
Key People
| | • |
Chairman:
John F. Chappell
| | • |
President, CEO, and Director:
Carolyn J. Logan
| | • |
EVP Finance and Administration and CFO:
Adam C. Derbyshire
|
|
|
